ASC THERAPEUTICS

asc-therapeutics-logo

ASC Therapeutics is a biotechnology company that focuses on discovering and developing cures for intractable diseases. The company was founded in 2008 and is based in Milpitas, California.

#SimilarOrganizations #People #Website #More

ASC THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Health Care

Founded:
2008-01-01

Address:
Milpitas, California, United States

Country:
United States

Website Url:
http://www.asctherapeutics.com

Total Employee:
51+

Status:
Active

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare DNS Digital Ocean ATT Barracuda Networks Odoo


Similar Organizations

angitia-biopharmaceuticals-logo

Angitia Biopharmaceuticals

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

aum-biotech-logo

AUM BioTech

AUM BioTech offers self-delivering Gene silencing products for basic and pre-clinical research.

biomcare-logo

BiomCare

BiomCare is a company who focuses on the importance of the gut microbiota for human health and well-being.

bisichem-logo

BiSiChem

BiSiChem is a biotechnology company that focuses on the drug discovery and development field.

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

mandalmed-logo

MandalMed

MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

protomer-technologies-logo

Protomer Technologies

Protomer Technologies is a biotechnology company that focuses on metabolic diseases.

tally-health-logo

Tally Health

Tally Healthโ„ข is a biotechnology company founded to change the way we age. Co-founded by longevity expert Dr. David Sinclair.

Current Employees Featured

ruhong-jiang_image

Ruhong Jiang
Ruhong Jiang CEO @ ASC Therapeutics
CEO
2020-06-01

oscar-segurado_image

Oscar Segurado
Oscar Segurado Chief Medical Officer @ ASC Therapeutics
Chief Medical Officer
2019-12-01

Official Site Inspections

http://www.asctherapeutics.com

  • Host name: 68.183.249.54
  • IP address: 68.183.249.54
  • Location: Santa Clara United States
  • Latitude: 37.3417
  • Longitude: -121.9753
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95051

Loading ...

More informations about "ASC Therapeutics"

About Our Company โ€“ ADC Therapeutics

Applicants outside of the U.S. must qualify as a charitable organization within the country where they reside. This interactive portal allows you to: 1) provide necessary information so ADCT โ€ฆSee details»

Antibody Drug Conjugates Cancer Treatment โ€“ ADC Therapeutics

ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025 March 20, 2025; ADC Therapeutics Makes Grants to New Employees โ€ฆSee details»

Our Leadership Team โ€“ ADC Therapeutics

US-CORP-NPS-00065 06/24 © 2025 ADC Therapeutics SA. All rights reserved. About ADCT. Overview; Vision and Values; Our Leadership Team; Our Board of DirectorsSee details»

Company: ASC Therapeutics

Company Type: Therapeutic development Main focus: Developing curative treatments for various diseases through a proprietary gene-editing platform, TARGATTโ„ข, and other gene-editing โ€ฆSee details»

ADC Therapeutics Announces Abstracts Accepted for Presentation โ€ฆ

3 days ago ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced abstracts detailing multiple โ€ฆSee details»

ASC Therapeutics - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

ADC Therapeutics Announces Updated Results from LOTIS-2 Trial โ€ฆ

May 11, 2023 [email protected] +44 7879 627205 Amanda Loshbaugh ADC Therapeutics [email protected] +1 917-288-7023 Media Mary Ann โ€ฆSee details»

ADC Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +1 908-731-5556 ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing โ€ฆSee details»

Medical Information Hub | ADC Therapeutics | HCP Site

You are now leaving the ADC Therapeutics Medical Information Hub. ADC Therapeutics does not necessarily endorse the organization associated with this link and takes no responsibility for โ€ฆSee details»

ADC Therapeutics Announces Abstracts Accepted for Presentation โ€ฆ

2 days ago /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced...See details»

Ameet Mallik, Our Board of Directors โ€“ ADC Therapeutics

Ameet Mallik joined ADC Therapeutics as CEO in May 2022. Mr. Mallik has over 25 years of industry experience. Most recently he served as CEO of Rafael Holdings, a novel cancer and โ€ฆSee details»

ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer

Dec 19, 2022 ADC Therapeutics SA (NYSE: ADCT) today announced the appointment of Jose โ€œPepeโ€ Carmona as Chief Financial Officer (CFO), effective December 19, 2022. He will serve โ€ฆSee details»

ADC Therapeutics Announces Abstracts Accepted for Presentation โ€ฆ

2 days ago ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced abstracts detailing multiple โ€ฆSee details»

Antibody Drug Conjugates Clinical Development - ADC Therapeutics

ADCT-602 is an ADC composed of a monoclonal antibody that binds to CD22 conjugated to a PBDโ€“dimer toxin. Once bound to a CD22-expressing cell, ADCT-602 is internalized into the โ€ฆSee details»

ADC Therapeutics Provides Business Updates

Jan 4, 2024 We prioritized our pipeline, strengthened our organization and implemented a disciplined capital allocation model to generate cost efficiencies,โ€ said Ameet Mallik, Chief โ€ฆSee details»

Contact Us - ADC Therapeutics

Report Adverse Reactions or Product Complaints. To report suspected adverse events or product complaints, please call us at 1-855-690-0340 and select prompt 1. You ...See details»

ADC Therapeutics Reports Third Quarter 2023 Financial Results โ€ฆ

Nov 7, 2023 3Q 2023 ZYNLONTA® 1 net sales of $14.3 million reflect disruption following restructuring of commercial organization, increased competition and higher gross-to-net โ€ฆSee details»

GSA eLibrary Contractor Information

A .gov website belongs to an official government organization in the United States. ... [email protected]: Web Address: SAM UEI: Y9MBZX2C5RU5: Socio โ€ฆSee details»

ADC Therapeutics Announces CEO Transition

May 9, 2022 [email protected] +44 7879 627205 Amanda Hamilton ADC Therapeutics [email protected] +1 917-288-7023 USA Media Mary Ann โ€ฆSee details»

Environmental, Social & Governance Report 2021 - ADC โ€ฆ

The organization while keeping our ESG initiatives in mind. I am proud of our accomplishments to date. We are committed to running a sustainable global business, defining our priorities for โ€ฆSee details»

linkstock.net © 2022. All rights reserved